Aspartic proteinases share a conserved network of hydrogen bonds (termed "fireman's grip"), which involves the hydroxyl groups of two threonine residues in the active site Asp-Thr-Gly triplets (Thr26 in the case of human immunodeficiency virus type 1 (HIV-1) PR). In the case of retroviral proteinases (PRs), which are active as symmetrical homodimers, these interactions occur at the dimer interface. For a systematic analysis of the "fireman's grip," Thr26 of HIV-1 PR was changed to either Ser, Cys, or Ala. The variant enzymes were tested for cleavage of HIV-1 derived peptide and polyprotein substrates. PR(T26S) and PR(T26C) showed similar or slightly reduced activity compared to wild-type HIV-1 PR, indicating that the sulfhydryl group of cysteine can substitute for the hydroxyl of the conserved threonine in this position. PR(T26A), which lacks the "fireman's grip" interaction, was virtually inactive and was monomeric in solution at conditions where wild-type PR exhibited a monomer-dimer equilibrium. All three mutations had little effect when introduced into only one chain of a linked dimer of HIV-1 PR. In this case, even changing both Thr residues to Ala yielded residual activity suggesting that the "fireman's grip" is not essential for activity but contributes significantly to dimer formation. Taken together, these results indicate that the "fireman's grip" is crucial for stabilization of the retroviral PR dimer and for overall stability of the enzyme.

Department of Biochemistry Institute of Organic Chemistry and Biochemistry Czech Academy of Science Praha Czech Republic

Zobrazit více v PubMed

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1456-60 PubMed

Adv Virus Res. 1992;41:193-239 PubMed

Nature. 1970 Aug 15;227(5259):680-5 PubMed

J Biol Chem. 1972 Jan 25;247(2):427-39 PubMed

Prog Biophys Mol Biol. 1972;24:107-23 PubMed

Proc Natl Acad Sci U S A. 1973 Jun;70(6):1734-8 PubMed

J Mol Biol. 1975 Aug 15;96(3):471-93 PubMed

Biochemistry. 1992 Oct 6;31(39):9491-501 PubMed

EMBO J. 1994 Jan 15;13(2):306-17 PubMed

J Biol Chem. 1994 Feb 18;269(7):4787-93 PubMed

Biochemistry. 1994 Aug 9;33(31):9351-7 PubMed

Eur J Biochem. 1995 Feb 15;228(1):191-8 PubMed

J Virol. 1995 May;69(5):2751-8 PubMed

J Gen Virol. 1995 Aug;76 ( Pt 8):1917-25 PubMed

J Virol. 1995 Nov;69(11):7180-6 PubMed

J Biol Chem. 1996 Mar 8;271(10):5458-63 PubMed

Protein Eng. 1996 Nov;9(11):997-1003 PubMed

Biol Chem. 1996 Dec;377(12):765-74 PubMed

Eur J Biochem. 1997 Feb 15;244(1):235-41 PubMed

FEBS Lett. 1997 Jun 16;409(3):357-60 PubMed

Eur J Biochem. 1997 Dec 1;250(2):559-66 PubMed

J Virol. 1998 Jun;72(6):4798-810 PubMed

Biochemistry. 1998 Jun 16;37(24):8735-42 PubMed

J Mol Biol. 1998 Oct 23;283(2):475-88 PubMed

Protein Eng. 1998 Nov;11(11):999-1005 PubMed

Protein Sci. 1999 Aug;8(8):1702-7 PubMed

Structure. 1999 Sep 15;7(9):1047-55 PubMed

Biochemistry. 1964 Mar;3:297-317 PubMed

Anal Biochem. 1978 May;86(1):142-6 PubMed

FEBS Lett. 1984 Aug 20;174(1):96-101 PubMed

Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PubMed

J Virol. 1986 Aug;59(2):284-91 PubMed

Nature. 1987 Sep 24-30;329(6137):351-4 PubMed

Anal Biochem. 1987 Nov 1;166(2):368-79 PubMed

Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90 PubMed

Nature. 1989 Aug 3;340(6232):397-400 PubMed

Science. 1989 Aug 11;245(4918):616-21 PubMed

Science. 1990 Apr 20;248(4953):358-61 PubMed

J Biol Chem. 1990 May 15;265(14):7733-6 PubMed

J Biol Chem. 1990 Jun 25;265(18):10492-6 PubMed

Methods Enzymol. 1990;185:60-89 PubMed

J Biol Chem. 1990 Oct 5;265(28):17348-54 PubMed

J Virol. 1991 Jan;65(1):272-80 PubMed

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9660-4 PubMed

J Biol Chem. 1991 Mar 15;266(8):4951-8 PubMed

Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3213-7 PubMed

Biochemistry. 1991 May 14;30(19):4663-71 PubMed

Biochemistry. 1991 Aug 6;30(31):7703-11 PubMed

Virology. 1991 Sep;184(1):417-22 PubMed

J Virol. 1991 Nov;65(11):6165-72 PubMed

EMBO J. 1992 Mar;11(3):1141-4 PubMed

Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62 PubMed

Precursors of Viral Proteases as Distinct Drug Targets

Inhibitor and substrate binding induced stability of HIV-1 protease against sequential dissociation and unfolding revealed by high pressure spectroscopy and kinetics

Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir

Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region

Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization